title: Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
abstract: T cells reactive to lipids and restricted by major histocompatibility complex (MHC) class I-like molecules represent more than 15% of all lymphocytes in human blood. This heterogeneous population of innate cells includes the invariant natural killer T cells (iNK T), type II NK T cells, CD1a,b,c-restricted T cells and mucosal-associated invariant T (MAIT) cells. These populations are implicated in cancer, infection and autoimmunity. In this review, we focus on the role of these cells in autoimmunity. We summarize data obtained in humans and preclinical models of autoimmune diseases such as primary biliary cirrhosis, type 1 diabetes, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, psoriasis and atherosclerosis. We also discuss the promise of NK T cell manipulations: restoration of function, specific activation, depletion and the relevance of these treatments to human autoimmune diseases.
authors.affiliation: INSERM, U986, Hospital Cochin/St Vincent de Paul, Université Paris Descartes, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Simoni
authors.forename: J
authors.initials: J
authors.lastname: Diana
authors.forename: L
authors.initials: L
authors.lastname: Ghazarian
authors.forename: L
authors.initials: L
authors.lastname: Beaudoin
authors.forename: A
authors.initials: A
authors.lastname: Lehuen
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology; D050197:Atherosclerosis / Q000276:immunology; D015551:Autoimmunity / Q000276:immunology*; D017321:Clinical Trials, Phase I as Topic; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology; D005260:Female; D005699:Galactosylceramides / Q000627:therapeutic use; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008297:Male; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology; D055611:Natural Killer T-Cells / Q000187:drug effects / Q000276:immunology*; D011565:Psoriasis / Q000276:immunology
chemical_list: D005699:Galactosylceramides; C493154:alpha-galactosylceramide